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Abstract
Quantitative cerebrospinal fluid (CSF) cultures provide a measure of disease severity in 
cryptococcal meningitis. The fungal clearance rate by quantitative cultures has become a primary 
endpoint for phase II clinical trials. This study determined the inter-assay accuracy of three 
different quantitative culture methodologies. Among 91 participants with meningitis symptoms in 
Kampala, Uganda during Aug-Nov 2013, 305 CSF samples were prospectively collected from 
patients at multiple time points during treatment. Samples were simultaneously cultured by three 
methods: 1) St. George’s 100mcL input volume of CSF with five 1:10 serial dilutions, 2 AIDS 
Clinical Trials Group (ACTG) method using 1000, 100, 10mcL input volumes, and two 1:100 
dilutions with 100 and 10 mcL input volume per dilution on seven agar plates; and 3) 10mcL 
calibrated loop of undiluted and 1:100 diluted CSF (loop). Quantitative culture values did not 
statistically differ between St. George-ACTG methods (P=0.09) but did for St. George-10mcL 
loop (P<0.001). Repeated measures pairwise correlation between any of the methods was high 
(r≥0.88). For detecting sterility, the ACTG-method had the highest negative predictive value of 
97% (91% St. George, 60% loop), but the ACTG-method had occasional (~10%) difficulties in 
quantification due to colony clumping. For CSF clearance rate, St. George-ACTG methods did not 
differ overall (mean −0.05±0.07 log10CFU/mL/day; P=0.14) on a group level; however, 
individual-level clearance varied. The St. George and ACTG quantitative CSF culture methods 
produced comparable but not identical results. Quantitative cultures can inform treatment 
management strategies.
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Introduction
Cryptococcal meningitis is the most common cause of adult meningitis in sub-Saharan 
Africa, causing ~20% of AIDS-related deaths.1,2 This substantial burden has made 
cryptococcal meningitis the target of renewed clinical research interest and created the need 
for standardized metrics to monitor disease progression. Quantitative cryptococcal culture 
provides a measure of disease severity in cryptococcal meningitis, has improved the 
understanding of rates of response to antifungal treatment, and is independently associated 
with clinical outcome.3,4 Yet, although quantitative culture burden is a prognostic indicator, 
quantitative CSF cultures are not used in routine care.
The rate of cerebrospinal fluid (CSF) fungal clearance, as measured by serial quantitative 
cultures and termed early fungicidal activity, is a common endpoint used in phase II clinical 
trials that assesses the microbiologic activity of novel antifungal induction regimens for 
cryptococcal meningitis.5 Various quantitative culturing methodologies are used to quantify 
CSF fungal burden; however, the reproducibility between techniques is unknown.
In this study, we directly compare three established methods of quantitative CSF cultures for 
Cryptococcus in order to compare their inter-assay performance against one another in terms 
of absolute colony counts per mL of CSF and the calculated early fungicidal activity of CSF 
yeast clearance. We also examined the correlation between quantitative cultures and 
automated cell counting.
Methods
We prospectively screened 91 HIV-infected participants with suspected cryptococcal 
meningitis at Mulago Hospital in Kampala, Uganda from August 13 through November 30, 
2013. CSF samples (n=305) were collected at diagnosis (n=86), and at days 3 (n=58), 7 
(n=60), 10 (n=44) 14 (n=45), and after day 19 (n=12) of follow-up during the pilot phase of 
the ASTRO-CM trial (ClinicalTrials.gov: NCT01802385). The ASTRO-CM pilot was a dose 
finding phase II clinical study of adjunctive sertraline 100–400mg/day added to 
amphotericin 0.7–1.0 mg/kg/day with fluconazole 800mg/day. Participants provided written 
informed consent, and applicable institutional review boards approved the study.
Fresh CSF specimens were simultaneously cultured by three different quantitative culture 
techniques of varying complexity. The “St. George’s Method,” as developed by Robert 
Larsen, Thomas Harrison, and colleagues, was the reference standard used for 
comparison.5–11 This method uses 100 µL input volume of undiluted CSF with five 
additional 1:10 serial dilutions in sterile H2O. Each Sabouraud dextrose agar plate received a 
100 µL volume of CSF and was distributed using five 4.5mm sterile glass marbles (Figure 
1A). The second method, as developed by Robert Larsen and used by the AIDS Clinical 
Trials Group (ACTG), employs multiple input volumes (1000, 100, 10 µL) of undiluted CSF 
and two sequential 1:100 dilutions each with two 100 µL and 10 µL input volume per 
dilution, distributed using an L-shaped spreader (Figure 1B). This ACTG method uses seven 
culture plates in total. Finally, a third, and deliberately simple “loop” method of a calibrated 
plastic 10 µL loop was used to plate undiluted and 1:100 diluted CSF onto two culture plates 
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(Figure 1C). Due to delays in receiving supplies, 10 µL loop cultures began in October 2013, 
one month after the first CSF sample was collected. For each method, CSF vortexing was 
performed prior to dilutions and prior to plating. For quantification of fungal CSF burden, 
distinct colonies on agar plates were counted and colony-forming units (CFU) per mL CSF 
were enumerated on the 10th day of culturing.
We performed additional quantitative analyses of CSF fungal burden at diagnosis. In order to 
quantify cryptococcal antigen titers in CSF, we performed Cryptococcal antigen lateral flow 
assays (CrAg LFA) using a strategy that minimized the number of LFAs needed to 
determine titer values (Supplemental Appendix). In addition, yeast cells were quantified 
using automated cell counts performed on 10 µL of undiluted CSF using the TC20 
Automated Cell Counter (Bio-Rad, Hercules, CA), and subtracting the CSF white cell count 
(determined by manual counting).
Statistical Analysis
All statistical analyses were performed using Stata/IC 13.1 (StataCorp LP, College Station, 
Texas) on log10-transformed culture values (log10 CFU/mL). We assessed the relationship 
between culture methods via linear mixed model with a random intercept for each 
participant. Qualitative agreement was also assessed with percent concordance. To compare 
the difference in individual cultures, a paired sample Student’s t-test was performed.
We compared the calculated early fungicidal activity of CSF yeast clearance between the St. 
George and ACTG culturing methodologies by establishing a clearance rate for each 
individual based on a within-subject linear regression. The 10 µL loop method had 
insufficient number of cultures for a robust comparison. Specifically, we explored the intra-
subject variability over time of 47 persons with culture-positive meningitis and at least two 
CSF cultures. The early fungicidal activity of the rate of clearance of Cryptococcus CFU/mL 
CSF per day is generally logarithmic (i.e., linear on log10 CFU/mL scale), and thus we 
considered the rate of clearance as calculated by linear regression.
Results
Among 91 participants with suspected meningitis, we performed 305 lumbar punctures and 
quantitative CSF cultures. Of the 91 persons, 66 (73%) participants had CSF CrAg detected 
compatible with cryptococcal meningitis. The remaining 25 CSF CrAg-negative, culture 
negative participants were excluded from comparative analyses. The demographics of the 
cohort were typical for cryptococcal meningitis with a median age of 37 years (interquartile 
range (IQR), 32-42) and 35% (n=32) women. The median CD4 count was 24 cells/µL (IQR, 
9-81), with 49% (n=45) currently receiving ART and 4% (n=4) having previously received 
ART but defaulted from HIV care. Seven (8%) patients had a prior diagnosis of cryptococcal 
meningitis. The median initial CSF WBC count was <5 (IQR, <5–70) cells/µL, and median 
CSF protein was 59 (IQR, 34-116) mg/dL. Table 1 displays the three quantitative culture 
methodologies and an automated cell count as performed in parallel on longitudinally 
collected CSF specimens over two weeks of induction antifungal therapy. At diagnosis, the 
median CSF quantitative culture among patients with a positive culture was 4.26 log10 
CFU/mL by the St. George’s reference method (IQR, 3.45 to 5.32 log10 CFU/mL; mean
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±SD, 4.34±1.27 log10 CFU/mL), and the median CSF CRAG LFA titer was 1:2,000 (IQR, 
1:300–1:4,000).
Quantitative Culture Agreement
A paired comparison of the St. George’s and ACTG methods indicated no significant 
difference between their results of the two assays (P=0.09 by paired t-test). However, the 
ACTG quantitative culture results were generally higher than the standard St. George’s 
method. For every 1-unit increase in log10 ACTG quantitative cultures, there was a 
corresponding 0.88 increase in log10 CFU/mL (95% CI, 0.84 to 0.93) using the St. George’s 
quantitative cultures among 229 valid culture pairs from CSF CrAg-positive participants. 
For every 1-unit increase in the 10 µL calibrated loop method results, there was a 
corresponding 0.89 increase in log10 CFU/mL from the St. George’s method (95% CI, 0.82 
to 0.96) among 133 pairs from CSF CrAg-positive participants (Supplemental Figure 1). A 
comparison of the ACTG and calibrated loop indicated a mean increase in 0.94 log10 
CFU/mL (95% CI, 0.85 to 1.03) in ACTG results for every 1-unit increase in the calibrated 
loop method among (n=127 pairs). Among patients who had additional lumbar punctures 
after 14 days of amphotericin B-based therapy, 34% (12/35) of participants’ CSF remained 
culture positive with a mean culture growth of 750 CFU/mL, 870 CFU/mL and 30 CFU/mL 
for the St. George’s, ACTG, and 10 µL loop methods, respectively, among those with 
positive cultures by any method.
Figure 2 displays the relationship between the St. George’s and ACTG methods, which had 
the strongest correlation (Pearson r2 for repeated measures = 0.92, P<0.001). Although the 
10 µL loop method absolute counts differed significantly, the loop method’s quantitative 
culture results did correlate well with the St. George’s method (r2 for repeated measures = 
0.89, P<0.001) and with the ACTG method (r2 for repeated measures = 0.88, P<0.001). 
Among paired cultures performed by St. George and ACTG methods, 62% (143/229) 
differed by less than ±0.5 log10 CFU/mL and 81% (181/229) differed by less than ±1.0 log10 
CFU/mL, excluding sterile cultures by both methods.
Intra-subject Variability in Early Fungicidal Activity
We explored the intra-subject variability in the calculated rate of CSF clearance over two 
weeks among 47 subjects with at least two CSF quantitative cultures to identify potential 
differences in assays. The mean early fungicidal activity for the St. George’s method was 
−0.45 log10CFU/mL CSF/day (95%CI, −0.56, −0.33). The mean early fungicidal activity for 
the ACTG method was −0.40 log10CFU/mL CSF/day (95%CI, −0.51, −0.29). The mean 
difference in the calculated rate of clearance for the ACTG method was −0.05 
log10CFU/mL/day (95%CI, −0.11 to 0.02, P=0.14) in comparison with the St. George’s 
method (Figure 4). Thus, the overall group mean and median estimates were similar by 
quantitative culture method when using the linear method. However, there was substantial 
variation on the individual participant level; the 10th and 90th percentiles for differences in 
the individual participant level calculated early fungicidal activity were −0.47 and +0.12 
log10 CFU/mL CSF/day. These differences generally increased when fewer quantitative 
culture results were available. When only two serial quantitative cultures were available, the 
median difference in estimated early fungicidal activity was −0.16 (IQR, −0.32, 0.05, n=14) 
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whereas when ≥3 cultures were available (with at least two with growth) the median 
difference was <-0.01 (IQR: −0.05, 0.07, n=33) between the St. George and ACTG methods. 
Thus, in real world use, the early fungicidal activity estimate did not differ for the overall 
cohort with respect to the particular quantitative culture methodology utilized, yet there were 
individual patient level differences when calculating the intra-subject early fungicidal 
activity.
Prediction of CSF Sterility, Limit of Detection
Based on the differences in volumes of CSF cultured with each technique, the limit of 
detection for the St. George quantitative culture is 10 CFU/mL, for the ACTG culture 1 
CFU/mL, and for the loop culture 100 CFU/mL of CSF. For each method, we determined 
the negative predictive value where a true sterile culture was a negative culture by all 
methods. Among all negative CSF cultures, the ACTG method had the highest negative 
predictive for predicting CSF sterility of 97% (60/62), representing when the ACTG culture 
was sterile, all culture methodologies were sterile. The negative predictive value was also 
high at 91% (105/115) for the St. George method using 100µL. Conversely, the 10µL loop 
method was relatively insensitive at low fungal burdens having only a 60% (46/77) negative 
predictive value for a negative 10 µL loop culture to represent a true sterile culture. In 4.3% 
(n=10) of 234 paired cultures the ACTG method detected low level fungal growth not 
identified by the other methods, consistent with using the largest culture volume. Only 1 of 
the 10 was on an initial diagnostic culture, with the other 9 obtained from follow-up cultures 
collected at time of therapeutic LPs, and all 10 patients were CSF cryptococcal antigen 
positive. The median quantitative culture result for these 10 samples was 16 CFU/mL 
(Range 2–79). The false negative diagnostic culture had only 2 CFU/mL by the ACTG 
method with a CSF CRAG LFA titer of 1:200.
Automated Cell Counter Quantification Method
The automated cell counter did not perform well, even when subtracting the CSF WBC cell 
count (R2=0.46, difference on Day 1 = +1.52 log10 CFU/mL, 95% CI, 1.01 to 2.03; 
P<0.001) as compared with St. George culture methodology. Supplemental Figure 2 
provides an image from the instrument. Automated cell counts did not decrease over 14 days 
of amphotericin B, counting yeasts both dead and alive.
Discussion
Overall, the ACTG and St. George’s methods of quantitative CSF cultures produced highly 
comparable results on a population level but not identical results on an individual level. The 
10 µL loop method, although quite simple, had a limited dynamic range with false negative 
cultures at low fungal burden and undercounting at high fungal burden. Despite these 
differences, the correlation between all three methods remained high, with repeated 
measures r2 values ≥0.88. These results suggest strong reproducibility of quantitative culture 
results between St. George’s and ACTG methods.
We observed a small yet statistically significant negative correlation between mean and 
difference between the St. George and ACTG methods, suggesting that as the CFU count 
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increased, the ACTG method tended to count slightly higher than the St. George method. 
This same trend was seen between ACTG and loop methods as well, suggesting that the 
ACTG method overall yielded slightly higher colony counts at the extremes of low and high 
CFUs. This is an expected difference as the ACTG used one additional culture plate both at 
the low and high end.
The ACTG method was best for predicting true CSF sterility. This is likely explained by the 
ACTG plating of 1 mL of undiluted CSF, with better ability to detect growth <50 CFU/mL. 
In this setting, 10 individuals were found to have actively growing Cryptococcus by the 
ACTG method and no other. Nine of these were on follow up specimens collected from later 
therapeutic LPs, which would have minimal clinical implication but theoretically could 
result in a slightly more accurate calculation of the early fungicidal activity rate. A single 
discordant diagnostic specimen with positive growth by the ACTG method only at 2 
CFU/mL was from a diagnostic lumbar puncture collected prior to antifungal treatment. In 
the setting of using CSF CrAg LFA for diagnosis, which is more sensitive than culture,12 the 
diagnostic implications are minimal. However if using India ink, low burden infections will 
be missed as the sensitivity of India ink is ~40% among persons with CSF cultures having 
<1,000 CFU/mL.12 These results suggest that a 1mL plate of undiluted CSF should be a 
consideration in a research setting when seeking to maximize culture detection.
Those with sterile CSF cultures by 14 days of antifungal therapy have historically had better 
survival, less immune reconstitution inflammatory syndrome, and less cryptococcal relapse 
compared with those with positive CSF cultures at 14 days when using fluconazole 
400mg/day consolidation therapy.13,14 Whether the absolute number of organisms which 
remain culture positive in the CSF at 14 days, or if there is a threshold level which further 
influences clinical outcomes, is unknown.
CRAG LFA titers are a strong method of estimating initial fungal burden, but CRAG titer 
correlation worsens over time and cannot determine the response to antifungal therapy.12,15 
Automated cell counts did not estimate fungal burden well, possibly as counting could not 
distinguish between living and dead Cryptococcus or cellular debris; however, even at 
baseline, automated cell counts correlated unexpectedly poorly with culture CFU counts. 
The automated cell counter reported could count cells 6–50 µm in diameter with a dynamic 
range between 50,000 and 10 million cells/mL (4.7–7 log10/mL), which should have been 
adequate but was not. Although most CSF samples registered on the cell counter, most often 
the automated counts far exceeded the CFU’s on culture, even when correcting for CSF 
WBCs. This difference could be due to poor automated counting or clumping of organisms 
on culture. In either scenario, automated cell counting using this particular instrument did 
not perform well.
Despite attempts to standardize the three culturing methods, problems in protocol 
application were identified that may affect feasibility in resource-limited settings. Common 
problems with quantitative cultures included: poor sample plating and spreading supplies, 
which lead to colony clumping and the inability to provide an accurate quantitative count. 
This was very common with the 10 µL loop method and occasionally occurred (~10%) with 
the ACTG method. With the ACTG method, the low sample volumes (e.g. 10 µL) on some 
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plates (e.g. plate 2, 4, and 6) may allow the sample to dry before adequate even spreading 
occurs, resulting in clumping. Marbles generally worked better than spreaders for even 
distribution. Lastly is a consideration of the resources necessary to conduct quantitative 
cultures, during this three month project, approximately 1,500 agar plates were used for the 
St. George method (n=5 per CSF specimen) and 1,700 plates for the ACTG method (n=7 per 
CSF specimen). Thus, the resources to conduct quantitative cultures in a busy hospital 
microbiology lab may be sizeable. Although on sequential samples, it may be possible to 
limit the number of plates used to the relevant number based upon the prior results or initial 
CRAG titer. For blood and CSF CRAG-negative persons, we routinely now use ~1mL CSF 
on one culture plate only.
Identification of cryptococcal disease and meningitis has now become rapidly and readily 
available with screening employing the CRAG LFA assay. Either 40 µL of blood or CSF can 
determine if cryptococcal disease is present within 10 minutes.16 It is now feasible for 
quantitative CSF cultures at baseline to become the mainstay of assessing severity of disease 
so that appropriate treatment decisions can follow. Baseline CSF quantitative cultures can be 
readily assessed at 4–7 days after incubation. Follow up cultures collected while receiving 
amphotericin-based induction therapy, in contrast, generally require longer incubation times 
with ~15% of samples requiring >14 days of incubation before becoming culture positive 
(Larsen, personal communication). Intensive antifungal therapy with amphotericin B (with 
or without fluconazole), offers the most effective antifungal therapy but is not broadly 
available. However, those with mild disease can likely be rapidly switched to fluconazole 
monotherapy if the initial fungal burden is low and the predicted response would lead to 
negative cultures by day 14. In those with higher baseline fungal burdens, when the 
predicted response to amphotericin B indicates that CSF culture would not be sterile by 14 
days for example, it may be prudent to evaluate the fungal burden at 14 days and consider 
continuing the amphotericin B based regimen or higher dose fluconazole (800–1200mg/day) 
until it is predicted the CSF cultures will be sterile. Future studies focused on 1) determining 
the optimal cutoffs of initial CSF fungal burden used for making antifungal duration 
decisions, and 2) evaluating the feasibility of a customized approach to antifungal therapy, 
are needed. However, shorter durations of amphotericin therapy could provide substantial 
cost savings to the healthcare system and limit toxicity in individuals with milder 
disease.9,17 This approach can only be enabled by performing quantitative CSF cultures, and 
ongoing assessment of the optimal method for quantitation that balances accuracy with 
practicality across various settings remains a priority.
Overall, the St. George’s and ACTG quantitative culture methods for Cryptococcus yielded 
highly reproducible but not identical results in a real world setting. We provide an example 
laboratory standard operating procedure template (Supplemental Appendix), based on the 
lessons of this project. Ultimately, the choice of quantitative culture method should be based 
upon local laboratory-specific capacity. In high-resource areas, quantitative CSF cultures 
should be routinely performed for CRAG-positive specimens.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Three Quantitative CSF Culture Methods
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Figure 2. Correlation between Quantitative Cultures by St. George Method and ACTG Method
Center reference line displays 1:1 correlation with boundaries displaying ±0.5 log10 
CFU/mL. Paired specimens (n=229) were collected on day 1 (n=52), day 3 (n=49), day 7 
(n=50), day 10 (n=34), day 14 (n=36), and after day 18 (n=8).
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Figure 3. Individual CSF Quantitative Culture differences between ACTG and St. George 
method
The two methods correlated well (β=0.88, 95% CI, 0.84 to 0.93) with the ACTG method 
having slightly higher overall average growth (+0.09 log10 CFU/mL). This was most 
apparent at the extremes of high and low culture values whereby the ACTG method tended 
to count slightly higher than the St. George method.
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Figure 4. 
Differences in calculated early fungicidal activity of the rate of CSF clearance for ACTG 
quantative culture method in comparison with St. George method as reference. Among 47 
participants with culture positive cryptococcal meninigitis and ≥2 CSF cultures, the mean 
difference in rate of clearance was −0.05 log10 CFU/mL/day (95%CI, −0.11 to 0.02, 
P=0.14).
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Table 1
Differences in Quantitative CSF Cultures by varied Techniques by Day of Treatment among persons with 
cryptococcal meningitis.
St. George Culture
Median (IQR)
ACTG Culture
Median (IQR)
10mcL Loop
Median (IQR)
Auto Cell Counter
Median (IQR)
Overall N 278 229 133 183
Day 1 4.0 (3.0, 5.1) 3.8 (2.6, 5.2) 3.5 (2.0, 3.9) 5.5 (5.0, 5.9)
Day 3 3.8 (2.3, 5.1) 3.7 (2.4, 5.4) 2.7 (0.0, 5.3) 5.7 (5.2, 6.3)
Day 7 2.1 (0.0, 3.5) 2.5 (1.0, 3.6) 0.0 (0.0, 2.5) 5.4 (5.0, 5.9)
Day 10 1.0 (0.0, 2.3) 1.2 (0.0, 3.3) 0.0 (0.0, 1.0) 5.2 (4.7, 5.7)
Day 14 0.0 (0.0, 2.3) 0.0 (0.0, 2.5) 0.0 (0.0, 0.0) 5.3 (4.8, 5.7)
>Day 14 0.5 (0.0, 2.8) 1.9 (0.3, 3.1) 0.0 (0.0, 2.5) 5.2 (0.0, 5.5)
Data are median (IQR) log10 colony forming units (CFU)/mL CSF collected among all persons with initial CSF cryptococcal antigen positivity, 
including sterile cultures. Twenty-five participants with negative CSF cryptococcal antigen and sterile cultures are not included.
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